Ohio HB8 requires health plans and Medicaid to cover biomarker testing for diagnosis, treatment, and monitoring of diseases.

Ohio HB8 mandates that health plans and Medicaid cover biomarker testing for diagnosis, treatment, and ongoing monitoring of diseases. This coverage is intended to improve health outcomes and reduce healthcare costs. The bill ensures that the Medicaid program covers biomarker testing in a way that minimizes disruptions in care, such as avoiding multiple biopsies. Appeals for coverage decisions must be accessible to providers and recipients. The bill aims to cover biomarker testing when supported by medical or scientific evidence, excluding screening purposes.

Ohio HB8 requires health plans and Medicaid to cover biomarker testing for diagnosis, treatment, and monitoring of diseases.

Ohio HB8 mandates that health plans and Medicaid cover biomarker testing for diagnosis, treatment, and ongoing monitoring of diseases. This coverage is intended to improve health outcomes and reduce healthcare costs. The bill ensures that the Medicaid program covers biomarker testing in a way that minimizes disruptions in care, such as avoiding multiple biopsies. Appeals for coverage decisions must be accessible to providers and recipients. The bill aims to cover biomarker testing when supported by medical or scientific evidence, excluding screening purposes.